75 %). At low probability, neither exercise electrocardiography nor scintigraphy provided incremental improvement In prognostic power. At intermedlate probability, individual increments were still small, but the overall increment was statistically signlflcant. At high probability, the increment for exercise electrocardiography alone became significant. Abbreviations as in Figures 1 and 2.
Volume
59
273
0.005]. Perfusion scintigraphy again had a modest additional effect on receiver operating characteristic curve area, similar to that in the intermediate-diseaseprobability group (Fig. 3). The average increment in area was 5 f 7% (73 - 68, p = 0.14). Combined testing with exercise ECG and scintigraphy resulted in an overall incremental gain of 18 f 7% (p
20
80
JOURNAL
nn -
2
+
380
-
YTERMEDlATl
LOW 296
*1* ,,I -++
70
162
275
+
+
HIGH
57
55
99
57
FIGURE 4. Exercise electrocardiography and prognosis. Patients are grouped by disease probablllty (Fig. 3) and by the exercise electrocardiographic response. Exercise electrocardiographic results were consldered negative (-) (< 1 mm ST depression, I55 % maximal heart rate), discordant (+) (
274
INCREMENTAL
ACCURACY
OF CORONARY
ARTERY
DISEASE
PROGNOSIS
area averaged only 58 f 8%. Both noninvasive tests, however, provided significant incremental prognostic power (Fig. 6). The increment associated with exercise ECG averaged 14 f 10% (72 - 58, p = 0.05) and that associated with scintigraphy averaged 14 f 8% (86 72, p = 0.01). As a result, exercise ECG provided additional prognostic stratification in these patients (event rate = 3% vs 1470, p = 0.04) (Fig. 7). Moreover, scintigraphy provided further prognostic stratification in patients with positive exercise ECGs (event rate = 0% vs 24%. p = 0.06) and in patients with discordant exercise ECGs (event rate = 2% vs 1670, p = 0.008) (Fig. 8).
Discussion
cians always have knowledge of at lease some aspects of the history and physical examination before they have knowledge of a test response. Despite this rather obvious fact, however, technologic assessment is often performed using analytic models that ignore the amount of information already known before testing or its ease of acquisition. For example, a group of investigators recently used stepwise discriminant function analysis to assess the utility of exercise radionuclide ventriculography in predicting subsequent coronary events soon after acute myocardial infarction.z5 Of 15 clinical, ECG and scintigraphic variables, discriminant analysis identi-
Our study confirms an earlier report indicating that the prior probability of disease is the most important descriptor of prognosis in patients referred for stress testing because of suspected CAD,l’ and shows that exercise ECG and scintigraphy each have additional prognostic power only in certain clinical subsets. These findings have direct relevance to the development of optimal testing strategies. The concept of incremental information: Clinical information is never interpreted in isolation. Physi-
”
PERFUSION SCINTIGRAPHY
3c )-
0.5 POSITIVE
FALSE
1
1.0 RATE
FIGURE 6. Receiver operatlng characteristic curves in patients with abnormal rest electrocardiographic findings. From the lowest to the highest, these curves represent clinical history (H), clinical history plus exercise electrocardiogram (H+E) and clinical history plus electrocardiography plus thallium scintigraphy (H+E+T).
*P-x
20 EVENT RATE (%I
20 1c
-
EXERCISE ELECTROCARDIOGRAPHY PRE-EXERCISE DISEASE PROSASILITY “=
-
f
60 12
2
21 39
7
2 F
+
HGH 13
p-=.05
36
FIGURE 5. Perfuslon scintigraphy and prognosis. Patients are grouped by disease probability (Fig. 3), by exercise electrocardlographic response (Fig. 4) and by scintlgraphic response. Sclntlgraphic findings were considered normal If anything less than moderate hypoperfusion was observed and were considered abnormalif moderate or severe hypoperfusion was observed. At low probabillty, scintlgraphy provided no additional prognostic discrimination. At intermediate probability, discrimination was improved for patients with positive (-I) exercise electrocardiographic responses, and at high probability, discrimination was improved for patients with dlscordant (A) exercise electrocardiographic responses. Htgh-probability patients with negatlve (-) electrocardiographic responses were at low risk and high-probability patients with positive (+) responses were at high risk, regardless of the sclntlgraphlc response.
10
5 2
rl 0
n=
+ EXERCISE ELECTROCARDIOGRAPHY 70 ID3 35
FIGURE 7. Exercise electrocardiography with abnormal rest electrocardiographic grouped as In Figure 4. Event rates abnormal exercise electrocardiographic
and prognosis in patients findings. Patlents are increased with increasingly response.
February
fied only the latter as providing significant prognostic information. On the basis of this analysis, the investigators concluded that exercise radionuclide ventriculography “is a highly sensitive means for classifying patients. . .according to the likelihood of having cardiac events” in the early months after myocardial infarction.25 When we performed discriminant analysis on a similar database, we too found the exercise ejection fraction to be the only variable with statistically significant prognostic value 26; but when we analyzed the data according to a clinically realistic hierarchy whereby the individual variables were considered for inclusion in the very same order in which they actually become available to the physician (first, the historical variables; second, the exercise ECG variables; third, the rest/exercise radionuclide variables), the exercise radionuclide variables no longer provided a significant increment of prognostic information.26 Similarly, Currie et alz7 showed that neither exercise ECG nor radionuclide ventriculography alone provided significantly more diagnostic information then did clinical history; only when the 2 stress tests were considered together was accuracy improved. Previous studies document the utility of clinical history,2*Jg exercise ECG1-12 and perfusion scintigraphy13-15 in assessing the prognosis of patients with suspected CAD, but they fail to recognize the incremental hierarchical nature of such information. The fact that historical information and rest ECG data are available to the clinician before exercise ECG and scintigraphic data has important implications for optimal utilization of these procedures. A testing strategy based on incremental information: A strategy for prognostic testing can be developed based on the incremental prognostic power of the in-
1, 1987
THE AMERICAN
JOURNAL
OF CARDIOLOGY
Volume
59
275
formation and the cost of obtaining that information. We shall here limit our discussion to monetary costs, although other costs are also likely to be important (Fig. 9). Since we assume that a brief history suitable for estimation of disease probability and a rest ECG will be recorded in all patients, only the cost of performing additional noninvasive tests will be considered. Perfusion scintigraphy performed in conjunction with exercise ECG is approximately 3 times more expensive than exercise ECG alone (about $750 and $250, respectively). The total cost of testing our entire population with both noninvasive tests, therefore, was $750 times 1,659, or $1,244,250. The strategy proposed in Figure 10 is based on the monetary costs noted above and on the empiric observations reported herein. At each decision point, additional testing is recommended only if such testing is capable of producing “significant” stratification of the negative and positive responders into appropriately low- and high-risk groups. We used the conventional threshold of p = 0.05 to define “significant” stratification, and we chose an event rate of 5% as the threshold between low and high risk. For example, in the case of high-disease-probability patients with positive ECG findings, there was an apparent difference between the event rates of 25% and 9% for patients with normal and abnormal scintigraphic findings, respectively. However, the difference was not significant (p = 0.14, and while 25% represented an unacceptably high risk, 9% did not represent an acceptably low risk. According to our strategy, therefore, the entire group of patients is considered at high risk (event rate = 19%], and further noninvasive testing is not recommended. Patients with normal rest ECG findings are first classified by disease probability. Patients with low
SCINTIGRAPHY 20
EVENT RATE (%I
10
ECG PRE-EXERCISE
@
EXERCISE ELECTRocARDKx+IAPHYO
I “=
41
29
66
37
FIGURE 9. Perfusion scintlgraphy and prognosls In patients wlth abnormal rest electrocardlographlc findings. Patients are grouped as in Figure 5. Prognostic discrimination was improved for patlents wlth discordant (k) exercise electrocardiographic responses.
DISEASE
PROBABILITY
FIGURE 9. The monetary cost of a uniform approach to prognostic assessment (exercise electrocardiography [ECG] and scintlgraphy in all patients) is compared to that of a sequential testing strategy. Sclntigraphy (which includes exercise ECG) is assumed to cost $750 and exercise ECG alone is assumed to cost $250. A sequential testing strategy is cost-effective in patients with normal ECG flndings. There is no savings in patients wlth abnormal rest electrocardiographic findings.
276
INCREMENTAL
ACCURACY
OF CORONARY
ARTERY
DISEASE
PROGNOSIS
probability are not further tested because they are at low risk. Patients with intermediate probability are referred for exercise ECG and those with a negative response (no ST depression at a normal level of stress] or a discordant response (no ST depression at a reduced level of stress or ST depression at a normal level of stress) are not further tested because they also are at low risk. Those with a positive exercise ECG response (ST depression at a reduced level of stress] are referred for scintigraphy. Patients with normal scintigraphic responses are considered to be at low risk and patients with abnormal scans are considered to be at high risk. Since only 57 (l2%] intermediate-diseaseprobablility patients proceed to scintigraphic testing, cost is reduced by $204,000. Similarly, all patients with high disease probability and normal rest ECG findings are referred for exercise ECG, and those with negative and positive responses are not further tested because they are at low and high risk, respectively, regardless of the subsequent scintigraphic response. In contrast, patients with discordant exercise ECG responses are referred for scintigraphy and defined as being at low and high risk according to the scintigraphic response. Only 99 (47%) patients with
NORMAL RESTING ELECTROCARDIOGRAM (SequentId TestIngI
mscaRDuIT
HEaATM
PERFUSION SCNTKYIAPNY
POSITlYE -ANT I
N(UTM
FERNSION SCINTIGRAPHY
I #aNmNu
- 1'I v 1
NnAL
HIGH RISK I
v 1 LOW
RISK
ABNORMAL RES77NG ELECTROCARDIOGRAM OJnlformRstlngl 1 EXERCISE-
high probability would be so referred for scintigraphy, reducing the cost of testing by $3l,OOO. All patients with abnormal rest ECG responses are referred for exercise ECG and scintigraphy. This is not associated with a cost reduction. As a result of this strategy a high-risk group amounting to 11% of the total population is defined, while the total cost of testing is reduced by $795,500 (64%). Highrisk patients so defined are presumed to be appropriate candidates for more aggressive therapy (coronary angioplasty or bypass surgery], while low-risk patients might be treated more conservatively. Limitations: Certain limitations of our study design and analysis should be noted. First, the design was necessarily retrospective, and not all variables with potential prognostic importance were considered. Second, event rates were sometimes estimated from relatively small subsets, and the confidence associated with these estimates was limited accordingly. For example, only 1 event occurred in the 12 patients with high disease probability with normal exercise ECG responses and abnormal scintigraphic findings. Because of the small sample size, however, the 95% confidence interval associated with this event rate of 8% ranges from 0 to 39%. Third, the cutpoints used to define patient subsets with respect to disease probability and test response were arbitrary, and despite the availability of computer decision aids such as those used by us to calculate disease probability, physicians are likely to perform such estimation tasks subjectively and to thereby incorporate a host of additional factors not considered in the present analysis. Fourth, the statistical threshold of p = 0.05 used to define significant prognostic stratification, and the event rate threshold of 5% used to define high- and low-risk groups are both arbitrary. Changes in these thresholds could materially change the recommendations that derive from the strategic model. Clinical application: To use this model, then, each physician must select his own thresholds for acceptable and unacceptable risk and cost. He or she can then use these thresholds to decide on the need for further testing based on the available empiric data and on the rules embodied in the model. The model thus provides the physician with an explicit framework within which to exercise his clinical judgment. Selective use of exercise testing procedures according to our strategic model thereby stratifies individual patient risk for subsequent coronary events over a full order of magnitude at a 64% reduction in monetary cost.
1
References
I FIGURE
HIGH
RISK
10. A proposed
LOW
rational
testing
RISK
strategy.
I
1. Bruce RA. DeRouen T, Peterson DR. Irving JB. Chinn N, Blake B. Hofer V. Noninvasive predictors of sudden cardiac death in men with coronary artery disease. Am J Cardiol 1977;39:833-840. 2. Epstein SE. Value and limitations of electrocardiographic response to exercise in the assessment of patients with coronary artery disease. Controversies in cardiology. Am J Cardiol 1978:42:667-674. 3. McNeer JF. Margolis JR, Lee KL, Kisslo JA. Peter RH, Kong Y. Behar VS. Wallace AG. M&ants CB, Rosati RA. The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation 1978;57:64-70. 4. Hammermeister KE, DeRouen TA. Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative qngiographic evaluation. Circulation 1979;59:421429.
February
5. Ivanova
LA, Mazur
NA. Smimova TM, Sumarokov AB. Nazarenko VA. exercise testing and ambulatory monitoring to identify patients with ischemic heart disease at high risk of sudden death. Am J Cardiol 1986;45:113.&1138. 6. Harris P]. Lee KL. Harrell FE, Behar VX, Rosati RA. Outcome in medically treated coronary artery disease. Ischemiti events non-fatal infarction and death. Circulation 1986;62:716-726. 7. Kennedy HL. Comparison of ambulatory electrocardiography and exercise testing. Am J Cardiol 1961;47:1359-1365. 8. Schneider RM. Seaworth JF. Dohrmann ML, Lester RM. Phillips HR. Bashore TM, Baker JT. Anatomic and prognostic implications of an early positive treadmill exercise test. Am J Cardiol 1962;50:682-688. 9. Gohlke H, Samek L. Betz P. Roskamm H. Exercise testing provides additional prognostic information in angiogmphically defined subgroups of patients with coronary artery disease. Circulation 1983;68:979-985. 10. Weiner DA, McCabe CH. Ryan TJ. Prognostic assessment of patients with coronary artery disease by exercise testing. Am Heart J 1983;105:749-755. 11. CASS Principal Investigators and their Associates. Coronary Artery Surgery Study [CASS). A randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983;68:939. 12. Weiner DA Ryan TJ. McCabe CH. Chaitman BR. Sheffield LT. Ferguson JC. Fisher LD. Tristani F. Prognostic importance of a clinical profile and exercise test in medicallv treated wtients with coronary artery disease. IACC 1984;3:772-779. 13. Ladenheim ML, Pollock BH, Rozanski A. Berman DS. Staniloff HM, Forrester IS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. JACC 1986:7:464-471. 14. Brown KA. Boucher CA, Okada RD. Guiney TE, Newell JB. Strauss HW. Pohost GM. Prognostic value of exercise thallium-281 imaging in patients presenting for evaluation of chest pain. JACC 1983;1:994-1001. 15. Pamelia FX, Gibson RS. Watson DD. Craddock GB. Sirowatka J. Beller GA. Prognosis with chest pain and normal thallium-201 exercise scintigrams. Am J Cardiol 1985;55:920-928. 16. Diamond GA. A clinically relevant classification of chest discomfort. JACC 1983;1:574-575. 17. Diamond GA, Staniloff HM, Forrester JS. Pollock BH, Swan HJC. ComElectrocardiographic
I
I
1. 1987
THE AMERICAN
JOURNAL
OF CARDIOLOGY
Volume
59
277
puter-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. JACC 1983;1:444-445. 18. Staniloff HS. Forrester JS, Diamond GA, Pollock BH. Swan HJC. The “CABG patch”: classification of coronary artery bypass surgical crossovers in medical studies (abstr). CIin Res 1984;32:228A. 19. Dixon WJ. BMDP Statistical Software. Berkeley. CA: University of CaIifornia Press, 1981:330-341. 20. Hanley JA. McNeil BJ. The meaning and use of the area under o receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. 21. McNeil Bj. Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (AOC] curves. Med Decis Making 1984;4:137-150. 22. Rozanski A, Diamond GA, Forrester JS, Berman DS. Morris D, Jones R, Okada R. Freeman M. Swan HJC. Should the intent of testing influence its interpretation? JACC 1986;7:17-24. 23. Diamond GA. ROC steady: a receiver operating characteristic curve which is invariant relative to selection bias. Med Decis Making, in press. 24. Hanley JA, NcNeiI BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983:148:839-843. 25. Corbett JR, Dehmer GJ. Lewis SE, Woodward W, Henderson E. Parkey RW. Blomquist CG, WilIerson JT. The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction. Circulation 1981:64;535-544. 26. Staniloff HM. Diamond GA, Forrester JS, Pollock BH. Berman DS, Swan HJC. The incremental information boondoggle: when a test seems powerful but isn’t. Circulation 1982;66:184. 27. Currie PH. Kelly MJ. Harper RW. Federman J, Kalff V. Anderson ST, Pitt BA. fncremental value of clinical assessment, supine exercise electrocardiography, and biplane exercise radionuclide ventriculography in the prediction of coronary artery disease in men with chest pain. Am J CardioI1983;52;927935. 28. Cole JP, Ellestad MH. Significance of chest pain during treadmill exercise: correlation with coronary events. Am J Cardiol 1876;41:227-232. 29. Cohn PF. Harris P. William BH, Rosati RA. Rosenbaum P. Watemaux C. Prognostic importance of angina1 symptoms of angina1 symptoms in angiogmphically defined coronary artery disease. Am J Cardiol 1981:487:223237.